Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 04, 2015 09:00 ET | Source: Cortex Pharmaceuticals, Inc.

Cortex Pharmaceuticals, Inc. Announces Publication of Research Results on the Use of Ampakines CX1739 and CX717 in the Treatment of Respiratory Disorders

GLEN ROCK, N.J., May 4, 2015 (GLOBE NEWSWIRE) -- Cortex Pharmaceuticals, Inc. (OTC:CORX) ("Cortex" or the "Company") announces the recent publication of two key scientific papers co-authored by the...
May 01, 2015 09:00 ET | Source: Cortex Pharmaceuticals, Inc.

Cortex Pharmaceuticals, Inc. to Present at NewYorkBIO 25th Anniversary Conference

GLEN ROCK, N.J., May 1, 2015 (GLOBE NEWSWIRE) -- Cortex Pharmaceuticals, Inc. (OTC:CORX) ("Cortex" or the "Company"), a leader in developing drugs for respiratory disorders, particularly sleep apneas...
April 06, 2015 06:00 ET | Source: Cortex Pharmaceuticals, Inc.

Cortex Pharmaceuticals, Inc. Files December 31, 2014 Annual Report on Form 10-K; Provides Update on Current Status and Activities

GLEN ROCK, N.J., April 6, 2015 (GLOBE NEWSWIRE) -- Cortex Pharmaceuticals, Inc. (OTC:CORX) ("Cortex" or the "Company") is a leader in developing drugs for respiratory disorders, particularly sleep...
January 09, 2015 08:00 ET | Source: Cortex Pharmaceuticals, Inc.

Cortex Pharmaceuticals, Inc. to Present at 7th Annual Biotech Showcase(TM) 2015

GLEN ROCK, N.J., Jan. 9, 2015 (GLOBE NEWSWIRE) -- Cortex Pharmaceuticals, Inc. (CORX) ("Cortex" or the "Company"), a leader in developing drugs for respiratory disorders, particularly sleep apneas and...
December 02, 2014 08:00 ET | Source: Cortex Pharmaceuticals, Inc.

Cortex Pharmaceuticals, Inc. to Participate in 7th Annual Biotech Showcase 2015(TM) Being Held in San Francisco, California From January 12 - 15, 2015

GLEN ROCK, N.J., Dec. 2, 2014 (GLOBE NEWSWIRE) -- Cortex Pharmaceuticals, Inc. (CORX) ("Cortex" or the "Company"), a leader in developing drugs for respiratory disorders, particularly drug-induced...
September 24, 2014 08:30 ET | Source: Cortex Pharmaceuticals, Inc.

Cortex Pharmaceuticals, Inc. Announces Phase 1 Funding by the National Institute of Drug Abuse, National Institutes of Health, Under the Small Business Innovation Research Funding Award Program

GLEN ROCK, N.J., Sept. 24, 2014 (GLOBE NEWSWIRE) -- Cortex Pharmaceuticals, Inc. (OTC:CORX) ("Cortex" or the "Company"), a leader in developing drugs for respiratory disorders, including drug-induced...
September 04, 2014 18:00 ET | Source: Cortex Pharmaceuticals, Inc.

Cortex Pharmaceuticals, Inc. to Present at Rodman & Renshaw 16th Annual Global Investment Conference

GLEN ROCK, N.J., Sept. 4, 2014 (GLOBE NEWSWIRE) -- Cortex Pharmaceuticals, Inc. (OTC:CORX) ("Cortex" or the "Company"), a leader in developing drugs for respiratory disorders, particularly...
September 04, 2014 17:28 ET | Source: Cortex Pharmaceuticals, Inc.

Cortex Pharmaceuticals, Inc. Announces Appointment of Two Directors; Expands Board to Five Members

GLEN ROCK, N.J., Sept. 4, 2014 (GLOBE NEWSWIRE) -- Cortex Pharmaceuticals, Inc. (OTC:CORX) ("Cortex" or the "Company"), a leader in developing drugs for respiratory disorders, including drug-induced...
July 01, 2014 05:30 ET | Source: Cortex Pharmaceuticals, Inc.

Cortex Pharmaceuticals, Inc. Enters Into New License Agreement With the University of Illinois Granting Cortex Patent Rights to the Use of Cannabinoids for the Treatment of Sleep Related Breathing Disorders

GLEN ROCK, N.J., July 1, 2014 (GLOBE NEWSWIRE) -- Cortex Pharmaceuticals, Inc. (OTC:CORX) ("Cortex" or the "Company"), a biopharmaceutical company currently engaged in the development of drugs for...